Tradestie Institutional Equity Comparison Engine
RENX vs CDIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CDIO Overall Edge
CDIO Captures Institutional Edge (1โ1 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cardio Diagnostics Holdings Inc. Common stock (CDIO) driven by superior Growth & Margin while RENX counters with relative strength in Momentum & Technical. Fundamentally, RENX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CDIO at N/M Forward P/E and -42649.8% operating margin (+25.7% YoY). In options structure, RENX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CDIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
RENX N/M vs CDIO N/M Fwd P/E
Growth & Margin Winner
CDIO
Op Margin N/A vs -42649.8% ยท YoY N/A vs +25.7%
Momentum & Technical Winner
RENX
1Y +163.6% vs -37.5% ยท 52W Pos 19% vs 9%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RENX
US Equity
RENX
Institutional Equity
$0.74
-23.09% 1D
Market Cap
N/A
1M Return
-48.21%
1Y Return
+163.59%
Forward P/E
N/M
Unified AI Score
44.0 / 100
HOLD
Tech 33.0
Fund 52.0
Flow 50.0
Mom 64.0
CDIO
NASDAQ
Cardio Diagnostics Holdings Inc. Common stock
In Vitro & In Vivo Diagnostic Substances
$1.60
-3.03% 1D
Market Cap
$4.9M
1M Return
-6.16%
1Y Return
-37.5%
Forward P/E
N/M
Unified AI Score
47.2 / 100
HOLD
Tech 40.0
Fund 50.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RENX +163.59%
CDIO -37.5%
Spread: +212.13 pp (RENX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RENX TTM Op. Margin: N/A
CDIO TTM Op. Margin: -42649.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RENX vs CDIO. Trailing 12-month operating profitability (RENX N/A vs CDIO -42649.8%) and valuation multiples (RENX N/M vs CDIO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RENX | CDIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $4.9M | Larger Scale | CDIO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +25.7% | Higher Growth | CDIO |
| Operating Margin (TTM) Profitability | N/A | -42649.8% | Higher Margin | CDIO |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | CDIO |
| Return on Equity (ROE) Capital Efficiency | N/A | -93.5% | Higher ROE | CDIO |
| 52-Week Range Position Momentum | 19% ($0โ$3) | 9% ($1โ$8) | Stronger Trend | RENX |
| Beta / 30D Volatility Risk Regime | -17.85ฮฒ ยท 161% Vol | 1.36ฮฒ ยท 56% Vol | Lower Realized Risk | CDIO |
| Unified Institutional Score Composite Signal | 44.0 / 100 (HOLD) | 47.2 / 100 (HOLD) | Higher Composite | CDIO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RENX vs CDIO Buy Guide
RENX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CDIO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RENX nor CDIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.